GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » Additional Paid-In Capital

Ocular Therapeutix (FRA:0OT) Additional Paid-In Capital : €1,076.76 Mil(As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix Additional Paid-In Capital?


Ocular Therapeutix's quarterly additional paid-in capital increased from Sep. 2023 (€633.60 Mil) to Dec. 2023 (€723.24 Mil) and increased from Dec. 2023 (€723.24 Mil) to Mar. 2024 (€1,076.76 Mil).

Ocular Therapeutix's annual additional paid-in capital increased from Dec. 2021 (€560.91 Mil) to Dec. 2022 (€615.69 Mil) and increased from Dec. 2022 (€615.69 Mil) to Dec. 2023 (€723.24 Mil).

Ocular Therapeutix Additional Paid-In Capital Historical Data

The historical data trend for Ocular Therapeutix's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Additional Paid-In Capital Chart

Ocular Therapeutix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 341.98 505.81 560.91 615.69 723.24

Ocular Therapeutix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 613.51 619.26 633.60 723.24 1,076.76

Ocular Therapeutix Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Ocular Therapeutix Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocular Therapeutix (FRA:0OT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » Additional Paid-In Capital
Comparable Companies
ATAI LCTX SELB TCRX EYPT XOMA MCRB ENTA FULC SCPH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
OCUL:USA 0OT:Germany
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Website
https://www.ocutx.com
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix (FRA:0OT) Headlines

No Headlines